|
DDOST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70760000004233E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.458790E-03 |
| Normal-vs-Stage2 |
1.245550E-01 |
| Normal-vs-Stage3 |
1.176990E-03 |
| Normal-vs-Stage4 |
2.966200E-02 |
| Stage1-vs-Stage2 |
6.754400E-01 |
| Stage1-vs-Stage3 |
3.138000E-02 |
| Stage1-vs-Stage4 |
1.611250E-01 |
| Stage2-vs-Stage3 |
4.775400E-01 |
| Stage2-vs-Stage4 |
6.274600E-01 |
| Stage3-vs-Stage4 |
9.622400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.8561000000058E-06 |
| Normal-vs-AfricanAmerican |
7.181500E-03 |
| Normal-vs-Asian |
2.637800E-02 |
| Caucasian-vs-AfricanAmerican |
3.667000E-01 |
| Caucasian-vs-Asian |
9.751400E-01 |
| AfricanAmerican-vs-Asian |
7.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.389700E-04 |
| Normal-vs-Female |
4.14359999978409E-07 |
| Male-vs-Female |
6.361200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.735800E-03 |
| Normal-vs-Extreme_Weight |
1.463460E-03 |
| Normal-vs-Obese |
2.828800E-04 |
| Normal-vs-Extreme_Obese |
6.417000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.596000E-01 |
| Normal_Weight-vs-Obese |
6.891800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.396400E-01 |
| Extreme_Weight-vs-Obese |
4.238400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.902200E-01 |
| Obese-vs-Extreme_Obese |
1.657400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.022300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.56531999999654E-05 |
| Normal-vs-Age(61-80Yrs) |
4.638000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.234620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.756200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.594640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.130610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.203200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.757400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.927200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.03959999999226E-05 |
| Normal-VS-Type2 PRCC |
6.419600E-02 |
| Normal-VS-KIRP CIMP |
1.149750E-02 |
| Normal-VS-Unclassified PRCC |
4.13360000000029E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.261500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.674200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.256580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.438400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.001610E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.009800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.762700E-03 |
| Normal-vs-N1 |
1.696130E-03 |
| Normal-vs-N2 |
1.531040E-01 |
| N0-vs-N1 |
2.490600E-01 |
| N0-vs-N2 |
8.405700E-02 |
| N1-vs-N2 |
2.794000E-01 |
|
|
